Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

E. Kandzari, David; L. Bhatt, Deepak; Brar, Sandeep; Devireddy, Chandan; Esler, Murray; Fahy, Martin; M Flack, John; T. Katzen, Barry; P. Lea, Janice; P. Lee, David; B. Leon, Martin; Ma, Adrian; M. Massaro, Joseph; Mauri, Laura; Oparil, Suzanne; W. O’Neill, William; R. Patel, Manesh; J. Rocha‐Singh, Krishna; A. Sobotka, Paul; P. Svetkey, Laura; R. Townsend, Raymond; L. Bakris, George

doi:10.1093/eurheartj/ehu441

Public

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

Published in European Heart Journal • Nov 16, 2014

Authors:

David E. Kandzari

Deepak L. Bhatt

Sandeep Brar

Abstract

AIMS: The SYMPLICITY HTN-3 randomized, blinded, sham-controlled trial confirmed the safety of renal denervation (RDN), but did not meet its primary efficacy endpoint. Prior RDN studies have demonstrated significant and durable reductions in blood pressure. This analysis investigated factors that may...

Subject

Medicine

Blood pressure

Ambulatory blood pressure

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!